These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 33245189

  • 1. Tachyplesin induces apoptosis in non-small cell lung cancer cells and enhances the chemosensitivity of A549/DDP cells to cisplatin by activating Fas and necroptosis pathway.
    Wu J, Chen X, Zhang J, Chen J, Wang Y, Wei T, Ma J, Li Y, Mo T, He Z, Zhang H.
    Chem Biol Drug Des; 2021 Apr; 97(4):809-820. PubMed ID: 33245189
    [Abstract] [Full Text] [Related]

  • 2. GLIPR1 modulates the response of cisplatin-resistant human lung cancer cells to cisplatin.
    Gong X, Liu J, Zhang D, Yang D, Min Z, Wen X, Wang G, Li H, Song Y, Bai C, Li J, Zhou J.
    PLoS One; 2017 Apr; 12(8):e0182410. PubMed ID: 28771580
    [Abstract] [Full Text] [Related]

  • 3. Circular RNA hsa_circ_0096157 contributes to cisplatin resistance by proliferation, cell cycle progression, and suppressing apoptosis of non-small-cell lung carcinoma cells.
    Lu H, Xie X, Wang K, Chen Q, Cai S, Liu D, Luo J, Kong J.
    Mol Cell Biochem; 2020 Dec; 475(1-2):63-77. PubMed ID: 32767026
    [Abstract] [Full Text] [Related]

  • 4. Effects of VBMDMP on the reversal of cisplatin resistance in human lung cancer A549/DDP cells.
    Wang CK, Zhang Y, Zhang ZJ, Qiu QW, Cao JG, He ZM.
    Oncol Rep; 2015 Jan; 33(1):372-82. PubMed ID: 25394854
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. β-elemene reverses the drug resistance of lung cancer A549/DDP cells via the mitochondrial apoptosis pathway.
    Yao CC, Tu YR, Jiang J, Ye SF, Du HX, Zhang Y.
    Oncol Rep; 2014 May; 31(5):2131-8. PubMed ID: 24627125
    [Abstract] [Full Text] [Related]

  • 8. Reelin Promotes Cisplatin Resistance by Induction of Epithelial-Mesenchymal Transition via p38/GSK3β/Snail Signaling in Non-Small Cell Lung Cancer.
    Li JM, Yang F, Li J, Yuan WQ, Wang H, Luo YQ.
    Med Sci Monit; 2020 Aug 07; 26():e925298. PubMed ID: 32764530
    [Abstract] [Full Text] [Related]

  • 9. Ginsenoside Rd reverses cisplatin resistance in non-small-cell lung cancer A549 cells by downregulating the nuclear factor erythroid 2-related factor 2 pathway.
    Chian S, Zhao Y, Xu M, Yu X, Ke X, Gao R, Yin L.
    Anticancer Drugs; 2019 Sep 07; 30(8):838-845. PubMed ID: 31415285
    [Abstract] [Full Text] [Related]

  • 10. Niclosamide enhances the cytotoxic effect of cisplatin in cisplatin-resistant human lung cancer cells via suppression of lung resistance-related protein and c-myc.
    Zuo Y, Yang D, Yu Y, Xiang M, Li H, Yang J, Li J, Jiang D, Zhou H, Xu Z, Yu Z.
    Mol Med Rep; 2018 Mar 07; 17(3):3497-3502. PubMed ID: 29257330
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Increased ABCC2 expression predicts cisplatin resistance in non-small cell lung cancer.
    Chen Y, Zhou H, Yang S, Su D.
    Cell Biochem Funct; 2021 Mar 07; 39(2):277-286. PubMed ID: 32815556
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. LncRNA NNT-AS1 is a major mediator of cisplatin chemoresistance in non-small cell lung cancer through MAPK/Slug pathway.
    Cai Y, Dong ZY, Wang JY.
    Eur Rev Med Pharmacol Sci; 2018 Aug 07; 22(15):4879-4887. PubMed ID: 30070323
    [Abstract] [Full Text] [Related]

  • 18. Integrated analysis of DNA methylation and mRNA expression profiling reveals candidate genes associated with cisplatin resistance in non-small cell lung cancer.
    Zhang YW, Zheng Y, Wang JZ, Lu XX, Wang Z, Chen LB, Guan XX, Tong JD.
    Epigenetics; 2014 Jun 07; 9(6):896-909. PubMed ID: 24699858
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. p32/OPA1 axis-mediated mitochondrial dynamics contributes to cisplatin resistance in non-small cell lung cancer.
    Yu CX, Peng ZQ, Wang T, Qu XH, Yang P, Huang SR, Jiang LP, Tou FF, Han XJ.
    Acta Biochim Biophys Sin (Shanghai); 2024 Jan 25; 56(1):34-43. PubMed ID: 38151998
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.